Inventor
Paul R. Hinton
Inventor
Sunnyvale, CA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12NMicroorganisms or enzymes8%
Y02ATechnologies for adaptation to climate change7%
A01HNew plants or non-transgenic processes for obtaining them5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07HSugars1%
PatentTitleYear
10,150,814Fc variants with improved complement activation201810,086,076Interleukin-13 binding proteins20189,592,293'Interleukin-13 binding proteins'20178,629,257'IL-12/p40 binding proteins'20148,624,007'Alteration of Fc-fusion protein serum half-lives by mutagenesis'20148,604,177'Interleukin-13 binding proteins'20137,915,388'Interleukin-13 binding proteins'20117,851,600'Anti-CCR5 antibody'20107,732,570'Alteration of Fc-fusion protein serum half-lives by mutagenesis'20107,700,739'IL-12/p40 binding proteins'20107,666,419'Anti-CCR5 antibody'20107,442,777'Cytotoxicity mediation of cells evidencing surface expression of CD63'20087,365,168'Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis'20087,361,740'Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis'20087,320,790'Humanized antibodies'20087,223,393'Amphiregulin antibodies and their use to treat cancer and psoriasis'20077,217,798'Alteration of Fc-fusion protein serum half-lives by mutagenesis'20077,217,797'Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis'20077,122,185'Anti-CCR5 antibody'20067,034,121'Antibodies against CTLA4'20066,218,149'Antibodies having modified carbohydrate content and methods of preparation and use'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001Based in Mountain View, CA, US· patent location history
2006–2008Patents assigned to PDL BIOPHARMA INC (6)· patent assignee history
2006–2018Based in Sunnyvale, CA, US· patent location history
2006Based in Fremont, CA, US· patent location history
2010Patents assigned to FACET BIOTECH CORP (3)· patent assignee history
2010–2011Patents assigned to ABBOTT LAB (2)· patent assignee history
2013–2018Patents assigned to ABBVIE INC (4)· patent assignee history
2013–2014Patents assigned to HINTON PAUL R (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PDL BIOPHARMA INC | 6 | 2006–2008 |
| ABBVIE INC | 4 | 2013–2018 |
| FACET BIOTECH CORP | 3 | 2010 |
| HINTON PAUL Rself | 3 | 2013–2014 |
| ABBOTT LAB | 2 | 2010–2011 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sunnyvale, California, US | 19 | 2006–2018 |
| Fremont, California, US | 1 | 2006 |
| Mountain View, California, US | 1 | 2001 |